Supplier SurModics Builds Up Whole-Products Strategy With Two Acquisitions
This article was originally published in The Gray Sheet
After recent buys of Creagh Medical and now NorMedix, device coatings and IVD specialty firm SurModics says it has built its business as a whole-product solutions provider to device companies.
You may also be interested in...
Glenmark hopes complex and respiratory products including a potential filing for generic Flovent pMDI can restore some lost sheen of its US business going forward, but a compliance comeback for its Monroe site may be pivotal to deliver material gains.
Embecta, which recently completed its spin-off from Becton Dickinson, is forging ahead with its insulin injector-based business strategy, GLP-1s be damned.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.